Literature DB >> 12789279

Melanoma etiology: where are we?

Margaret A Tucker1, Alisa M Goldstein.   

Abstract

Melanoma incidence rates are rising rapidly, particularly in older men. Older men are also more likely to have thick melanomas, which confer high mortality and morbidity. The reasons for the rate of increase are not known; increasing sun and UV exposure, however, is the major hypothesized explanation. In the past several years, two major susceptibility genes for melanoma, CDKN2A and CDK4, have been identified, but the two genes together account for a minority of familial melanoma. Other high-risk susceptibility genes are being sought actively. Genetic epidemiologic studies suggest that penetrance of each of the two identified genes is altered by other factors, either genetic or environmental. Epidemiologic studies have also identified other major host factors important in the development of melanoma. In European, North American, and Australian populations, the presence of clinically identified dysplastic nevi confers greatly increased risk of melanoma. A new measure of sun exposure, based on individual residential history, confers substantially increased risk of melanoma. Recent surveys of sun behavior in the US reveal extensive sunburning and use of tanning beds in adolescents and adults. Sun protective behaviors are not as prevalent as in Australia, where population rates of melanoma are stabilizing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789279     DOI: 10.1038/sj.onc.1206444

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

1.  Increased risk of second primary cancers after a diagnosis of melanoma.

Authors:  Porcia T Bradford; D Michal Freedman; Alisa M Goldstein; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2010-03

2.  A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation.

Authors:  David L Duffy; Grant W Montgomery; Wei Chen; Zhen Zhen Zhao; Lien Le; Michael R James; Nicholas K Hayward; Nicholas G Martin; Richard A Sturm
Journal:  Am J Hum Genet       Date:  2006-12-20       Impact factor: 11.025

3.  Functional modulation of IGF-binding protein-3 expression in melanoma.

Authors:  Altaf A Dar; Shahana Majid; Mehdi Nosrati; David de Semir; Scot Federman; Mohammed Kashani-Sabet
Journal:  J Invest Dermatol       Date:  2010-04-01       Impact factor: 8.551

Review 4.  Skin cancer-related prevention and screening behaviors: a review of the literature.

Authors:  Nadine A Kasparian; Jordana K McLoone; Bettina Meiser
Journal:  J Behav Med       Date:  2009-06-12

Review 5.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Authors:  Foteini Chatzinasiou; Christina M Lill; Katerina Kypreou; Irene Stefanaki; Vasiliki Nicolaou; George Spyrou; Evangelos Evangelou; Johannes T Roehr; Elizabeth Kodela; Andreas Katsambas; Hensin Tsao; John P A Ioannidis; Lars Bertram; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2011-06-21       Impact factor: 13.506

6.  A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  Cancer Causes Control       Date:  2008-09-24       Impact factor: 2.506

7.  [Malignant melanoma masquerading as a neurotrophic ulcer].

Authors:  Larissa Schöttler; Andreas Körber; Natalia Denisjuk; Julia Freise; Joachim Dissemond
Journal:  Med Klin (Munich)       Date:  2009-09-23

8.  "Melanoma: Questions and Answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma.

Authors:  Nadine A Kasparian; Shab Mireskandari; Phyllis N Butow; Mbathio Dieng; Anne E Cust; Bettina Meiser; Kristine Barlow-Stewart; Scott Menzies; Graham J Mann
Journal:  Support Care Cancer       Date:  2016-07-27       Impact factor: 3.603

9.  cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca(2+) homeostasis in melanoma cells.

Authors:  Alexandr V Bazhin; Vojtech Tambor; Boyan Dikov; Pavel P Philippov; Dirk Schadendorf; Stefan B Eichmüller
Journal:  Cell Mol Life Sci       Date:  2009-11-28       Impact factor: 9.261

10.  14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.

Authors:  Julia Schultz; Saleh M Ibrahim; Julio Vera; Manfred Kunz
Journal:  Mol Cancer       Date:  2009-07-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.